BioMedTech February 4, 2019 FDA grants Fast Track designation for the development of PTX3003 in the treatment of patients with Charcot-Marie-Tooth disease type 1a
BioMedTech January 15, 2019 Positive interim results from the first part of the PIVOTAL study Positive interim results from the first part of the PIVOTAL study (10 patients) ...
BioMedTech January 1, 2019 Les Echos, Investir | Deinove leaps onto the stock market, the American army demonstrates the effectiveness of its antibiotic against bioterrorism